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Introduction {#sec1}
============

During development, cells lose their pluripotent status and acquire a stable cell identity, which only rarely, if ever, changes to another kind. Yet, somatic cells can be reprogrammed to another cell fate by nuclear transfer (NT) to eggs ([@bib14]), by the expression of a combination of transcription factors ([@bib36]) or by cell-cell fusion ([@bib3]). In these reprogramming procedures, the gene-expression pattern and epigenetic state characteristic of one differentiated cell identity is erased and the gene expression pattern specific to another cell type is established.

However, the efficiency of complete reprogramming via NT is low, as less than 10% of NT embryos generated from differentiated cells reach adulthood ([@bib14], [@bib26]). This led to the hypothesis that differentiated cells acquire a resistance to reprogramming procedures, which during normal development, helps to stabilize their cell fate. Due to this resistance, eggs cannot fully reprogram the incoming somatic nuclei, so that embryos with aberrant gene expression patterns arise and normal embryonic development is not supported ([@bib12], [@bib16], [@bib28]). So far, it has been shown that a failure in reactivating genes, e.g., the pluripotency gene Oct4, during nuclear reprogramming is indicative of a poor developmental outcome of NT embryos ([@bib5]). Furthermore, epigenetic modifications inhibiting the re-activation of genes during the reprogramming procedure have been investigated and their removal has been utilized to improve reprogramming efficiency and to increase the viability of NT embryos ([@bib4], [@bib6], [@bib10], [@bib19], [@bib23], [@bib25]). However, the expression of donor cell-type-specific genes in the wrong cell type of NT embryos could also lead to a severe disruption of normal gene expression patterns resulting in developmental defects and embryonic lethality. Indeed, the existence of such an active transcription state memory has been suggested in NT and induced pluripotent stem cell (iPSC) experiments ([@bib30], [@bib18], [@bib28]). Currently, however, the extent and functional importance of persistent donor-cell-type-specific gene expression in resistance to reprogramming is not known. Furthermore, the epigenetic mechanisms that confer memory of an active state of gene expression and that maintain the differentiated state of cells during nuclear reprogramming and embryonic development remain elusive.

Here we show that in *Xenopus* and human NT embryos, memory of an active transcriptional state (ON-memory) is a phenomenon as widespread as the memory of an inactive transcriptional state. ON-memory genes are associated with increased levels of the active histone mark H3K4me3 when compared to properly reprogrammed genes in *Xenopus* and human somatic donor cells. Importantly, while a reduction in H3K4 methylation levels has little effect on gene expression in the donor cells, it significantly improves transcriptional reprogramming and enhances the developmental potential of the resultant NT embryos in *Xenopus*. Our study thus identifies H3K4 methylation as a critical epigenetic barrier in NT-mediated reprogramming and implicates its role as stabilization mechanism of cell differentiation.

Results {#sec2}
=======

Identification of Reprogramming Resistant ON-Memory Genes Expressed in the Wrong Cell Type of NT Embryos {#sec2.1}
--------------------------------------------------------------------------------------------------------

The low success rate of current cloning strategies was suggested to be partly due to the persistence of a donor-cell-type-specific gene expression pattern in NT embryos, which could hinder the generation of new cell types ([@bib11], [@bib23], [@bib25]). As a first step to test this hypothesis, we evaluated the extent of memory gene expression in *Xenopus* NT embryos on a transcriptome-wide level.

For this purpose, the nucleus of a neurula-stage endoderm cell was transplanted to an enucleated egg to obtain NT embryos and as a control for normal gene expression, in vitro fertilized (IVF) embryos were generated ([Figure 1](#fig1){ref-type="fig"}A). Properly cleaved embryos were collected at the gastrula stage, a time point where ectoderm and endoderm identity is established and before any developmental defects can be observed in these NT embryos. Endoderm donor cells as well as ectoderm cells of single NT and IVF embryos were then subjected to RNA sequencing (RNA-seq) analysis in biological triplicate ([Figures 1](#fig1){ref-type="fig"}A and [S1](#mmc1){ref-type="supplementary-material"}A--S1F; [Tables S1](#mmc1){ref-type="supplementary-material"} and [S2](#mmc1){ref-type="supplementary-material"}). To test the extent of memory and reprogramming in the newly generated cell type, we addressed which transcripts differ between endoderm donor cells and ectoderm cells of IVF embryos. When the expression of these genes also differs between NT- and IVF- ectoderm cells, we consider them to be examples of donor cell memory ([Figure S1](#mmc1){ref-type="supplementary-material"}A). If they are expressed at similar levels in NT and IVF, we consider them as reprogrammed ([Figure S1](#mmc1){ref-type="supplementary-material"}B). Of all 24,215 identified transcripts ([Figure 1](#fig1){ref-type="fig"}B, in gray), a large number (17,587; [Table S2](#mmc1){ref-type="supplementary-material"}) was differentially expressed between endoderm donor cells and ectoderm cells of IVF embryos. 13,083 of these genes were reprogrammed as they were expressed at similar levels in the ectoderm of NT and control IVF embryos ([Table S2](#mmc1){ref-type="supplementary-material"}). In contrast, 4,504 genes were resistant to reprogramming as they were differentially expressed between ectoderm cells of NT and control IVF embryos ([Figures 1](#fig1){ref-type="fig"}B and 1C). This gene set included 1,534 ON-memory genes- these are genes that were expressed in donor endoderm cells and continued to be significantly (false discovery rate \[FDR\] ≤ 0.05) upregulated in NT ectoderm cells when compared to IVF ectoderm cells ([Figures 1](#fig1){ref-type="fig"}B and 1C, group 1). Another 1,346 of the same gene set are described as OFF-memory genes, because their transcripts were expressed at significantly (FDR ≤ 0.05) lower levels in ectoderm cells of NT embryos when compared to IVF controls ([Figure 1](#fig1){ref-type="fig"}B and 1C, group 4). The remaining 1,624 genes were either too much down- or upregulated in the ectoderm of NT embryos when compared to the IVF controls ([Figure 1](#fig1){ref-type="fig"}C, group 2 and group 3, respectively). We therefore see that a total of 2,880 ON-memory and OFF-memory genes are not reprogrammed by NT to eggs in *Xenopus*, and instead remember their donor cell expression pattern. Furthermore, this result suggests that NT embryos show endoderm ON-memory gene expression to the same extent as OFF-memory gene expression in the newly generated ectoderm cell type.Figure 1Donor Cell-Type-Specific Genes Are Expressed in the Wrong Cell Type of NT Embryos(A) Design of NT experiments.(B) MA plot comparing gene expression between ectoderm of NT and IVF embryos. The average log2 FC in expression of transcripts in NT embryos over IVF embryos is plotted on the y axis, and the mean log2 (1+RPKM) gene expression in the donor endoderm cells is plotted on the x axis. Gray, all transcripts; orange, ON-memory genes; black, OFF-memory genes; red, ON-memory(3FC) genes; blue, OFF-memory(3FC) genes.(C) Heatmap showing 4,504 differentially expressed transcripts obtained by pairwise comparison between donor endoderm cells and IVF and NT ectoderm cells. Rows are log2 FC in expression over mean expression levels in IVF. Hierarchical clustering of rows classified those genes into four groups. Gene ontology analysis revealed that ON-memory genes are enriched for genes important for endoderm development; FDR, false discovery rate; FC, fold change.See also [Figures S1](#mmc1){ref-type="supplementary-material"} and [S4](#mmc1){ref-type="supplementary-material"} and [Tables S1](#mmc1){ref-type="supplementary-material"} and [S2](#mmc1){ref-type="supplementary-material"}.

To obtain insight into biological processes associated with the inappropriately reprogrammed genes, we performed gene ontology analysis. This revealed that as a whole, reprogramming resistant genes are enriched for genes involved in development, transcriptional activity, and metabolic processes ([Figure 1](#fig1){ref-type="fig"}C). Importantly, we observed that the ON-memory gene set was enriched for genes implicated in endoderm development ([Figure 1](#fig1){ref-type="fig"}C, group 1). Furthermore, we found that master regulators of endoderm specification in *Xenopus*, such as *sox17* and *gata6*, were among the ON-memory genes showing the highest upregulation in NT embryos when compared to IVF ([Figure S1](#mmc1){ref-type="supplementary-material"}C). Hence, these results point toward retention of endoderm donor cell identity in the ectoderm cells of the NT embryos.

Next, we investigated the mechanism by which the ON-memory gene transcripts are accumulated in the ectoderm cells of the NT embryos. In *Xenopus*, there is no transcription for the first 12 cell cycles of embryonic development ([@bib17]). Consistently, we did not observe gene expression of the ON-memory genes *sox17β*, *gata6*, and *a2m (endodermin)* at stage 7, prior to zygotic genome activation (ZGA; [Figures S1](#mmc1){ref-type="supplementary-material"}G and S1H). This indicates that there was no carry-over of transcripts for these genes during NT, and that transcripts detected here were newly synthetized after ZGA. We therefore conclude that the memory of an active state of gene transcription of the donor nucleus was transmitted to its mitotic progeny during early embryonic cell divisions in the absence of the conditions that induced that state, and independently of ongoing gene transcription. It implies that the memory of the donor cell gene expression pattern observed in NT embryos is stabilized by epigenetic mechanisms.

ON-Memory Genes Are Enriched for H3K4me3 in Endoderm Donor Nuclei in *Xenopus* {#sec2.2}
------------------------------------------------------------------------------

We then investigated which epigenetic feature of the donor nuclei could account for the fact that ON-memory genes resist the reprogramming process and commence expression in the wrong cell type of NT embryos. Actively transcribed genes are characterized by the presence of methylated lysine 4 on histone H3 (H3K4me3) ([@bib35]). We hypothesized that accumulation of H3K4me3 following transcription of endoderm genes in donor cells could confer ON-memory gene-expression after NT.

Our transcriptome analysis identified reprogrammed-down genes that were active in endoderm donor cells ([Figure 2](#fig2){ref-type="fig"}A) but are reprogrammed and downregulated to IVF levels in the ectoderm of NT embryos ([Figure 2](#fig2){ref-type="fig"}B). ON-memory genes were initially expressed in endoderm donor cells at similar levels to reprogrammed-down genes ([Figure 2](#fig2){ref-type="fig"}A). However, they remained significantly upregulated in ectoderm cells of the NT embryo when compared to IVF (ON-memory; [Figure 2](#fig2){ref-type="fig"}B). Within the ON-memory group, a subset were especially resistant to reprogramming as they were more than 3-fold overexpressed (ON-memory(3FC); [Figure 2](#fig2){ref-type="fig"}B). Using these three sets of genes we tested if differences in H3K4me3 features could explain resistance to transcriptional reprogramming. We performed H3K4me3 chromatin immunoprecipitation sequencing (ChIP-seq) analysis on neurula-stage endoderm donor cells in biological duplicate ([Figures 2](#fig2){ref-type="fig"}C--2F and [S2](#mmc1){ref-type="supplementary-material"}A--S2D). The intensity of the H3K4me3 ChIP-seq signal around the transcriptional start site (TSS) was significantly higher in ON-memory genes when compared to reprogrammed-down genes ([Figures 2](#fig2){ref-type="fig"}C and 2D). Previous studies suggested that broad H3K4me3 domains are linked to cell identity and transcriptional consistency ([@bib2]), and since endoderm ON-memory genes are also enriched for endoderm lineage genes and maintain their transcriptionally active state even after the nuclear reprogramming procedure, we tested if ON-memory genes showed high H3K4me3 breadth. Indeed, when comparing the empirical cumulative distribution of H3K4me3 domain size spanning the TSS, ON-memory(3FC) genes showed significantly broader H3K4me3 domains than reprogrammed-down genes ([Figure 2](#fig2){ref-type="fig"}E). For example, the ON-memory genes *gata6* and *sox17β* are marked by broader domains than the reprogrammed-down gene *abhd4* ([Figure 2](#fig2){ref-type="fig"}F).Figure 2ON-Memory Genes Are Enriched for H3K4me3 in *Xenopus* and Human Donor Cells(A) Reprogrammed-down, ON-memory, and ON-memory(3FC) genes have similar expression levels in donor-endoderm cells (p values \> 0.4, Mann-Whitney test).(B) ON-memory-genes are upregulated in NT cells when compared to IVF ectoderm cells. Boxplot comparing mean expression levels of reprogrammed-down (^∗^p value = 1.024 × 10^−7^), ON-memory (^∗^p value \< 2.2 × 10^−16^), and ON-memory(3FC)-genes (^∗^p value \< 2.2× 10^−16^); Mann-Whitney test.(C--F) H3K4me3 ChIP-seq data generated from neurula-stage endoderm cells. Read counts are normalized by input and total mapped reads. (C) ON-memory-genes are enriched for H3K4me3 in donor-endoderm cells. Boxplot comparing mean H3K4me3 ChIP-seq intensities in a 4-kb window centered on the TSS (^∗^p value \< 0.001, KS test). (D) TSS metaplots of H3K4me3 ChIP-seq intensity in endoderm cells. ON-memory(3FC) and ON-memory ChIP-seq intensities are higher when compared to reprogrammed-down genes (p value = 0.07 and ^∗^p value = 0.001, respectively KS test). (E) ON-memory(3FC)-genes show increased H3K4me3 breadth when compared to reprogrammed-down genes (p value = 0.0002, KS test). Empirical cumulative distribution function (ECDF) comparing H3K4me3 domain size spanning the TSS. (F) Breadth distribution of H3K4me3 ChIP-seq peaks. Inserts are examples of H3K4me3 regions of a reprogrammed-down gene (*abhd4*) and ON-memory genes *sox17β.1* and *gata6*(NM_001087983.1).(G) MA plot comparing gene expression between human NT and IVF embryos. The average log2 FC in expression of transcripts in NT embryo over IVF embryos (n = 1; pool of five NT and of five IVF 8-cell embryos) is plotted on the y axis, and the mean log2 (1+FPKM) gene expression in the endoderm donor cells (1 sample of the donor dermal fibroblast cells, DFB-8) is plotted on the x axis. Gray, all identified transcripts; orange, ON-memory(2-5FC); black, OFF-memory(2-5FC); red, ON-memory(\> 5FC) genes; blue, OFF-memory(\> 5FC) genes.(H) Boxplot comparing mean expression levels of reprogrammed-down, ON-memory(2-5FC), and ON-memory(\> 5FC) genes in DFB-8 donor cells (^∗^p values \< 0.002, Mann-Whitney test).(I) ON-memory genes are upregulated in eight-cell NT embryos when compared to IVF embryos. Boxplot comparing mean expression levels of reprogrammed-down, ON-memory(2-5FC), and ON-memory(\> 5FC) genes (^∗^p values \< 2.2× 10^−16^) in eight-cell NT and IVF embryos; statistical test: Mann-Whitney test.(J and K) H3K4me3 ChIP-seq datasets of H3K4me3 in human dermal fibroblast cells (NHDF-cells) were obtained from the ENCODE project ([@bib8]). (J) TSS meta-plots of the average intensity of H3K4me3 modifications in NDHF cells for reprogrammed-down, ON-memory(\> 2FC), and all genes of the human genome. ON-memory(\> 2FC) ChIP-seq intensities are significantly higher when compared to reprogrammed-down genes (^∗^p value \< 0.035, 1 kb window around the TSS, KS test). (K) ECDF comparing H3K4me3 domain size around the TSS of reprogrammed-down, ON-memory(\> 2FC), and all genes from the human genome. ON-memory(\> 2FC)-genes do not show a significant increase in H3K4me3 breadth when compared to reprogrammed-down genes (p value = 0.85, KS test; ChIP-seq peaks called by MACS2).Boxplots: middle line in the box indicates the median; box edges indicate 25th/75th percentiles; and whiskers indicate min and max. See also [Figures S2](#mmc1){ref-type="supplementary-material"} and [S4](#mmc1){ref-type="supplementary-material"} and [Table S2](#mmc1){ref-type="supplementary-material"}.

These results suggest that ON-memory genes are enriched for H3K4me3, as they show higher ChIP-seq intensity and broader domains of this mark when compared to reprogrammed-down genes in the endoderm donor cells. Increased H3K4me3 levels and breadth could act together as barrier to cell-fate changes and hence explain why the set of memory-ON genes are resisting the reprogramming process.

The Phenomenon of ON-Memory Is Conserved in Human NT Embryos, and ON-Memory Genes Are Enriched for H3K4me3 in Human Donor Cells {#sec2.3}
-------------------------------------------------------------------------------------------------------------------------------

Our observations in *Xenopus* prompted us to investigate if ON-memory gene expression is conserved in human NT embryos and whether ON-memory genes, when compared to reprogrammed-down genes, are also enriched for H3K4me3 levels in the human donor cells. In previous studies ([@bib6], [@bib25]), epigenetic marks correlating with ON-memory genes were not addressed. Therefore, we obtained the published RNAseq datasets generated from pools of human eight-cell IVF embryos, as well as from eight-cell NT embryos using human dermal fibroblast (DFB-8) cell nuclei as donors ([@bib6]).

Our transcriptome comparison between the donor DFB cells and IVF and NT embryos identified a set of 76 ON-memory genes that remained more than 5-fold upregulated in NT embryos when compared to IVF control (ON-memory(\> 5FC); [Figures 2](#fig2){ref-type="fig"}G--2I). A set of 364 genes showed partial inactivation (ON-memory(2-5 FC)) ([Figures 2](#fig2){ref-type="fig"}G--2I) and a third set of 508 genes was efficiently downregulated in the NT-embryo when compared to IVF (reprogrammed-down; [Figures 2](#fig2){ref-type="fig"}I and 2J).

Therefore, our analysis of human NT embryo RNA-seq data suggests that the phenomenon of ON-memory gene expression is conserved in human NT embryos.

We then investigated the H3K4me3 ChIP-seq intensities of ON-memory and reprogrammed-down genes using publicly available H3K4me3 ChIP-seq datasets for NHDF cells, which are related to the DFB-8 cells used as donors to generate the NT embryos. In agreement with the results obtained for *Xenopus*, ON-memory genes showed increased H3K4me3 intensity around their TSS when compared to reprogrammed-down genes ([Figure 2](#fig2){ref-type="fig"}J). However, when comparing H3K4me3 domains breadth of ON-memory genes and reprogrammed-down genes, we could not observe a significant difference ([Figure 2](#fig2){ref-type="fig"}K).

These results suggest that also in human, high H3K4me3 levels at the TSS could confer ON-memory gene expression in NT embryos and hence act as barrier to nuclear reprogramming.

H3K4 Demethylation of Donor Nuclei Improves Transcriptional Reprogramming in *Xenopus* NT Embryos {#sec2.4}
-------------------------------------------------------------------------------------------------

Having established a correlation between ON-memory gene expression and H3K4me3 enrichment, we next asked whether this modification is responsible for resistance to reprogramming.

Hence, one-cell embryos were injected with mRNA encoding the H3K4-specific demethylase Kdm5b^wt^, or with Kdm5b^ci^, the catalytic inactive version of the enzyme, and grown to neurula-stage ([Figure 3](#fig3){ref-type="fig"}A). Western blot analysis confirmed that Kdm5b^wt^-expressing embryos showed reduced H3K4me3 levels when compared to uninjected embryos ([Figure 3](#fig3){ref-type="fig"}B). Furthermore, H3K4me3 ChIP-RTqPCR analysis verified the reduction in H3K4me3 levels following Kdm5b^wt^ treatment around the TSS and in the gene body of candidate ON-memory genes ([Figure S2](#mmc1){ref-type="supplementary-material"}E). We then used Kdm5b^wt^- and Kdm5b^ci^-expressing neurula-stage endoderm cells as donors to generate NT(Kdm5b^wt^) embryos and NT(Kdm5b^ci^) embryos, respectively ([Figure 3](#fig3){ref-type="fig"}A). As controls, we in vitro fertilized embryos. We collected gastrula stage embryos and subjected them, as well as the endoderm donor cells, to RNA-seq analysis ([Figure 3](#fig3){ref-type="fig"}A; [Tables S1](#mmc1){ref-type="supplementary-material"} and [S3](#mmc1){ref-type="supplementary-material"}).Figure 3Kdm5b Expression in the Donor Nuclei Reduces H3K4me3 Levels and Improves Reprogramming in NT Embryos(A) Design of NT experiments.(B) Western blot analysis indicating that Kdm5b^WT^ expression reduces H3K4me3 by ≈70% in neurula-stage embryos, when compared to uninjected ones.(C and D) Kdm5b^wt^ expression in the donor cells reduces the number of misregulated genes in NT embryos when compared to IVF embryos. MA plot comparing gene expression between NT(Kdm5b^ci^) and IVF ectoderm cells (C) or NT(Kdm5b^wt^) and IVF ectoderm cells (D). Average log2 FC in expression of transcripts in NT over IVF ectoderm cells is plotted on the y axis, and the mean log2 (1+RPKM) gene expression in the donor-endoderm cells is plotted on the x axis. Gray, all transcripts; orange, ON-memory genes; black, OFF-memory genes; red, ON-memory(3FC)genes; blue, OFF-memory(3FC) genes.(E) ON-memory gene expression is reduced in NT(Kdm5b^wt^) embryos. Heatmap showing the expression of ON-memory genes identified in NT(Kdm5b^ci^) embryos in donor-endoderm cells in IVF, NT(Kdm5b^ci^), and NT(Kdm5b^wt^) ectoderm cells. Rows represent log2 FC in expression of the indicated samples over mean pooled expression levels of all samples. Rows were sorted by hierarchical clustering.(F) Boxplots comparing mean expression levels of ON-memory transcripts in donor-endoderm cells and IVF, NT(Kdm5b^ci^), and NT(Kdm5b^wt^) ectoderm cells. (^∗^p values \< 0.0004, Mann-Whitney test.)(G) Hierarchical transcriptome clustering analysis of filtered and normalized RNaseq data of single ectoderm tissues of IVF, NT(Kdm5b^wt^), and NT(Kdm5b^ci^) embryos, as well as donor endoderm cells.Boxplots: middle line in the box indicates the median; box edges indicate 25th/75th percentiles; and whiskers indicate min and max. See also [Figures S2--S4](#mmc1){ref-type="supplementary-material"} and [Tables S1](#mmc1){ref-type="supplementary-material"} and [S3](#mmc1){ref-type="supplementary-material"}.

First, we addressed the effect of H3K4 demethylation on gene expression in donor cells. Interestingly, we identified that only 102 out of 24,758 identified transcripts were differentially expressed between Kdm5b^WT^ and Kdm5b^ci^ treated donor cells ([Table S3](#mmc1){ref-type="supplementary-material"}). Therefore, changes in H3K4 methylation do not result in strong changes of gene expression levels, as reported previously ([@bib7]). Second, we addressed if H3K4 methylation is important for stabilizing an active state of gene expression by evaluating if genes lose resistance to reprogramming as well as their ON-memory state following Kdm5b^wt^ treatment of the donor cell. Transcriptome comparison of Kdm5b^ci^ expressing endoderm donor cells, the ectoderm of IVF embryos and NT(Kdm5b^ci^) embryos identified 1,434 reprogramming resistant genes as they were differentially expressed between ectoderm cells of NT(Kdm5b^ci^) and IVF embryos ([Figure 3](#fig3){ref-type="fig"}C). By comparison, in NT(Kdm5b^wt^) embryos, the number of reprogramming resistant genes was substantially reduced, as our analysis identified only 573 differentially expressed genes between the ectoderms of NT(Kdm5b^wt^) embryos and IVF embryos ([Figure 3](#fig3){ref-type="fig"}D). Importantly, Kdm5b^wt^ treatment of the donor cells significantly reduced ON-memory gene expression from 231 ON-memory(3FC) genes in NT(Kdm5b^ci^) embryos ([Figure 3](#fig3){ref-type="fig"}C) to 140 ON-memory(3FC) genes in NT(Kdm5b^wt^) embryos ([Figure 3](#fig3){ref-type="fig"}D). While the expression levels of ON-memory genes in the donor tissues was unaffected by the treatment with Kdm5b^wt^ when compared to Kdm5b^ci^, we observed a significant reduction of average ON-memory gene expression levels in NT(Kdm5b^wt^) embryos when compared to NT(Kdm5b^ci^) embryos ([Figures 3](#fig3){ref-type="fig"}E and 3F). Hierarchical clustering ([Figure 3](#fig3){ref-type="fig"}G), as well as principal component analysis (PCA) ([Figures S2](#mmc1){ref-type="supplementary-material"}F and S2G) of the transcriptome revealed that three out of seven NT(Kdm5b^wt^) embryos have a gene expression pattern in their ectoderm cells that is more similar to the one of IVF embryos than to the one of control NT(Kdm5b^ci^) embryos.

This implicates that expression of Kdm5b^wt^ in the donor cell reduces ON-memory gene expression and is able to improve the whole transcriptome of the resultant NT embryos.

Next, we analyzed the expression of selected candidate ON-memory genes (*sox17β*, *gata6*, *foxA4*, *a2m*, and *darmin)* during gastrulation of NT and IVF embryos via qRT-PCR. In donor endoderm cells, ON-memory gene expression was not affected by H3K4 demethylation ([Figures S2](#mmc1){ref-type="supplementary-material"}H--S2L). We observed that ON-memory genes were upregulated in NT(Kdm5b^ci^) ectoderm cells at all stages of gastrula embryos ([Figures S2](#mmc1){ref-type="supplementary-material"}M--S2Q). While *sox17β*, *gata6* and *foxA4* showed a decrease in gene expression in NT(Kdm5b^wt^) ectoderm cells at all stages ([Figures S2](#mmc1){ref-type="supplementary-material"}M--S2O), *a2m* and *darmin* were insensitive to Kdm5b^wt^ treatment of the donor cell as they did not show a significant reduction in gene expression in the resultant NT(Kdm5b^wt^) ectoderm cells when compared to NT(Kdm5b^ci^) ectoderm cells ([Figures S2](#mmc1){ref-type="supplementary-material"}P--S2Q). We propose that this is due to an additional, unknown epigenetic barrier other than H3K4me3, as we could observe that H3K4me3 levels were reduced at the TSS and at the gene body of *darmin* to a similar extent as of the other, Kdm5b^wt^ sensitive ON-memory genes ([Figure S2](#mmc1){ref-type="supplementary-material"}E). These results corroborate that Kdm5b^wt^ treatment can reduce ON-memory gene expression in the resultant NT embryos throughout gastrulation.

Finally, we confirmed that the observed reduction in ON-memory gene expression following Kdm5b^wt^ expression is indeed due to the demethylation of H3K4. We reduced H3K4me3 levels in the donor cells by expressing a dominant-negative version of histone H3.3 (H3.3^K4M^) that binds and inhibits the SET domain of H3K4-specific methyltransferases ([@bib20]). Transcriptome comparison between donor cells, the ectoderm cells of IVF embryos and of the NT(H3.3^wt^) embryos or NT(H3.3 ^K4M^) embryos corroborated the finding that a reduction of H3K4 methylation decreases ON-memory gene expression in NT embryos ([Figure S3](#mmc1){ref-type="supplementary-material"}; [Table S3](#mmc1){ref-type="supplementary-material"}).

Together, our data show that a H3K4 demethylation of donor nuclei not only improves the reprogramming of ON-memory genes but can also restore the global transcriptome of NT embryos.

H3K4 Demethylation in Donor Nuclei Improves the Development of NT Embryos {#sec2.5}
-------------------------------------------------------------------------

Finally, we investigated whether H3K4 demethylation in donor cells and the associated reduction in ON-memory gene expression in the resultant NT embryos are able to improve their survival.

We generated NT embryos from Kdm5b^wt^- and Kdm5b^ci^-treated donor cells, and while they developed to properly cleaved early gastrula embryos at a similar rate ([Figures 4](#fig4){ref-type="fig"}A and 4B; [Table S1](#mmc1){ref-type="supplementary-material"}), NT(Kdm5b^wt^) embryos showed fewer morphological abnormalities when compared to NT(Kdm5b^ci^) embryos ([Figures 4](#fig4){ref-type="fig"}A and 4B; [Table S1](#mmc1){ref-type="supplementary-material"}) as development proceeded. Notably, NT(Kdm5b^wt^) embryos reached the feeding tadpole stage and beyond at a significantly higher rate than NT(Kdm5b^ci^) embryos ([Figure 4](#fig4){ref-type="fig"}C). The developmental potential of NT(Kdm5b^ci^) embryos was consistent with previous results using uninjected endoderm cells as donors for NT ([@bib14]), as 30% of cleaved NT(Kdm5b^ci^) embryos reached the feeding tadpole stage ([Figures 4](#fig4){ref-type="fig"}B and 4C). Instead, the developmental outcome of NT(Kdm5b^wt^) embryos was comparable to the one of NT embryos generated from undifferentiated blastula cells ([@bib14]), as 60% of all cleaved embryos reached the feeding tadpole stage ([Figures 4](#fig4){ref-type="fig"}B and 4C).Figure 4H3K4 Demethylation in Donor Nuclei Improves the Development of NT Embryos(A) IVF, NT(Kdm5b^ci^), and NT(Kdm5b^wt^) embryos at the gastrula and tadpole stages.(B) The development of IVF, NT(Kdm5b^ci^), and NT(Kdm5b^ci^) gastrula embryos (stage 10.5) was followed until feeding tadpole stage (green lines and black solid line, respectively). Black dashed lines indicate the developmental potential of NT embryos generated from uninjected blastula stage or neurula stage endoderm nuclei (data from [@bib14]). y axis is the percentage of gastrula embryos reaching the indicated stages.(C) Kdm5b^WT^ expression in the donor cell improves the development of NT embryos to the feeding tadpole stage. Bar graph showing the percentage of cleaved gastrula embryos reaching the feeding tadpole stage (^∗^p value = 0.0007, paired t test, one-tailed). Data are presented as mean ± SEM.See also [Figure S4](#mmc1){ref-type="supplementary-material"} and [Table S1](#mmc1){ref-type="supplementary-material"}.

These results show that H3K4 methylation acts as a barrier to nuclear reprogramming, and that its removal significantly improves the developmental potential of NT embryos.

Discussion {#sec3}
==========

Our study identifies H3K4 methylation as an epigenetic barrier to nuclear reprogramming and suggests it as a safeguarding mechanism for cellular identity. Challenging the stability of cell identity through NT reveals epigenetic mechanisms that inhibit the activation of genes supporting alternative cell fates ([@bib6], [@bib23], [@bib25]). Here, we describe an epigenetic layer that prevents the inactivation of genes during nuclear reprogramming and ensures the stable expression of genes characteristic of an established cell identity. We observe that H3K4 methylation imposes memory of an active transcriptional state and that its suppression results in improved transcriptional reprogramming and an enhancement of the developmental outcome of *Xenopus* NT embryos. Therefore, our study shows that interfering with an epigenetic barrier and the associated ON-memory can improve the generation of new cell types by reprogramming via NT.

By transplanting differentiated nuclei to eggs, we uncover a function of H3K4 methylation in epigenetic memory of cell fate that extends beyond ensuring transcriptional consistency and maintaining ongoing gene transcription ([@bib2]). Indeed, reduction of H3K4 methylation by either demethylase or histone mutant expression has very little effect on endodermal cell transcription in fertilized embryos. However, the role of H3K4me3 in stabilizing a transcriptional program becomes most evident when the endoderm cell chromatin undergoes reprogramming by the egg: The early phase of frog embryogenesis encompasses a period of intense cell division in the absence of transcription. After ZGA, when cells are again permissive for transcription, H3K4me3 can induce endoderm ON-memory gene expression in ectoderm cells of cloned embryos. Hence we can differentiate in our experimental system the function of H3K4me3 in simply maintaining ongoing transcription, as observed in pluripotent cells ([@bib27]), from its function as an epigenetic memory factor of somatic cell identity.

The stabilization of an active transcriptional state correlates with increased intensity and breadth of H3K4 methylation around these genes, as for example around the endoderm lineage genes *sox17β* and *gata6*. During DNA replication, the modified nucleosomes are locally redistributed between the two daughter strands ([@bib31]) and broad H3K4me3 domains of ON-memory genes could ensure that the mark on these key lineage genes is faithfully propagated to the mitotic progeny, even when the chromatin is challenged by the egg's reprogramming factors and in the absence of gene transcription. Our results underline the importance of H3K4me3 as a safeguarding mechanism of cell identity.

ON-memory gene expression is conserved in *Xenopus* and human NT embryos and correlates with increased H3K4me3 levels in the somatic donor cell nuclei. It is likely that also in mammals, H3K4 methylation imposes a barrier to nuclear reprogramming and its removal enhances the efficiency of cloning. Interestingly, recent studies in mouse NT embryos suggest that a failure in reactivating Kdm5b expression during reprogramming correlates with a poor developmental outcome ([@bib23]), which would support that NT embryos with reduced Kdm5b levels might not be able to efficiently erase H3K4 methylation mediated ON-memory. However, studies also show that Kdm5b knock down in IVF embryos results in aberrant major ZGA ([@bib9]) and embryonic lethality. It is currently unknown if the developmental failure of mouse NT embryos is due to the normal requirement of Kdm5b for ZGA or if it is due to persistent ON-memory gene expression. In our work, we erase H3K4 methylation marks in the donor cells, and leave the H3K4me3 demethylation activities of the NT embryo unperturbed, and hence are able to show that ON-memory indeed acts as barrier to nuclear reprogramming. We propose that both, ON-memory gene expression due to persistent active marks and as well as a lack in Kdm5b activities, which are important for ZGA and development ([@bib9]), contribute to embryonic lethality in mouse NT embryos.

Once the essential epigenetic barriers conferring ON- and OFF-memory are identified, they can be targeted to improve reprogramming efficiencies and allow the generation of high quality stem cells suitable for cell replacement therapies.

STAR★Methods {#sec4}
============

Key Resources Table {#sec4.1}
-------------------

REAGENT or RESOURCESOURCEIDENTIFIER**Antibodies**H3K4me3Abcamab8580; RRID: [AB_306649](nif-antibody:AB_306649){#intref0010}HASigmaH9658; RRID: [AB_260092](nif-antibody:AB_260092){#intref0015}H4Abcamab31830; RRID: [AB_1209246](nif-antibody:AB_1209246){#intref0020}**Chemicals, Peptides, and Recombinant Proteins**Magnetic beads conjugated with secondary antibodyInvitrogen11204D**Critical Commercial Assays**TruSeq RNA library prep kitIlluminaRS-122-2001TruSeq DNA kitIlluminaFC-121-2001**Deposited Data**Raw and analyzed dataThis paperGEO: [GSM733650](ncbi-geo:GSM733650){#intref0025}**Experimental Models: Organisms/Strains***Xenopus laevis* wild type, mature femalesNascoLM00535MX*Xenopus laevis* wild type, mature malesNascoLM00715MX**Recombinant DNA**pCS2+ Kdm5b aa1-770- NLS-6HAThis paperaccession number [NM_152895](ncbi-n:NM_152895){#intref0030}pCS2+ Kdm5b H499A aa1-770- NLS-6HAThis paperaccession number [NM_152895](ncbi-n:NM_152895){#intref0035}pCS2+ H3.3-6HAThis paperaccession number [NM_001098432](ncbi-n:NM_001098432){#intref0040}pCS2+ H3.3K4M-6HAThis paperaccession number [NM_001098432](ncbi-n:NM_001098432){#intref0045}**Sequence-Based Reagents**RTqPCR primers ([Table S4](#mmc1){ref-type="supplementary-material"})SigmaNA**Software and Algorithms**Sickle<https://github.com/najoshi/sickle><https://github.com/najoshi/sickle>cutadapt 1.0[@bib24]<https://pypi.python.org/pypi/cutadapt/1.0>TopHat 2.0.6[@bib39]<https://ccb.jhu.edu/software/tophat/index.shtml>BWA (version 0.6.2)[@bib21]<https://sourceforge.net/projects/bio-bwa/files/>samtools 0.1.8[@bib22]edgeR[@bib33]<https://bioconductor.org/packages/release/bioc/html/edgeR.html>bedtools (version 2.25.0)[@bib32]<https://github.com/arq5x/bedtools2/releases>R version 3.2.4<https://www.R-project.org/><https://www.R-project.org/>gplots package version 3.0.1<https://CRAN.R-project.org/package=gplots><https://CRAN.R-project.org/package=gplots>

Contact for Reagent and Resource Sharing {#sec4.2}
----------------------------------------

Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Eva Hörmanseder <e.hoermanseder@gurdon.cam.ac.uk>

Experimental Model and Subject Details {#sec4.3}
--------------------------------------

Mature *Xenopus laevis* males and females were obtained from Nasco (901 Janesville Avenue, PO Box 901, Fort Atkinson, WI 53538-0901; <https://www.enasco.com/xenopus>). Our work with *Xenopus laevis* is covered under the Home Office Project License PPL 70/8591 and frog husbandry and all experiments were performed according to the relevant regulatory standards. Animals were maintained in a recirculating fresh water system (Marine Biotech) at a density of one adult/3l, with 10% water change per day and temperatures ranging from 16°C to 20°C. Water was sequentially filtered with mechanical pad sump filter, nitrifying bacteria filter, mechanical canister filter, carbon filter, and UV sterilized. Water quality parameters were as follow: conductivity 1500us; temperature 17-22°C; PH 6-8. Photoperiod was set to 12h ON/12h OFF. Frogs are fed twice per week with Royal Horizon 4.5mm pellets (skretting, <https://www.skrettingfishfeeds.co.uk/>). Unconsumed food was removed 10 min after the start of feeding. All material used for this work involves killing of testis-donating frogs by an overdose of anesthetic. Females are injected with hormones (50 units pregnant mare serum gonadotropin, 3 days in advance of egg laying, and 500 units human chorionic gonadotropin, 1 day in advance of egg laying) in the dorsal lymph sack to induce natural ovulation and egg laying in 1xMMR (100mM NaCl, 2mM KCl, 1mM MgSO4, 2mM CaCl2, 0.1mM EDTA, 5mM HEPES (pH 7.8). After egg laying, frogs underwent a health check by a veterinarian and were given a resting period of at least 3 months before re-use. These procedures were of minimal invasiveness and did not cause stress or suffering to the animal. The researchers and the staff of the Gurdon Institute animal husbandry facility are trained in these experiments, and veterinarians monitor the health status of the animals.

Method Details {#sec4.4}
--------------

### mRNA production {#sec4.4.1}

Mouse Kdm5b (accession number [NM_152895](ncbi-n:NM_152895){#intref0120}, aa1-770) and its catalytic inactive (ci) mutant (H499A; aa1-770), both with an C-terminal NLS-tag, as well as *Xenopus* H3.3 (accession number [NM_001098432](ncbi-n:NM_001098432){#intref0125}) and its dominant-negative mutant (K4M) constructs were sub-cloned into pCS2+ plasmid with 6 C-terminal HA-tags using the gateway cloning system (Thermo Fisher Scientific). mRNA was synthetized in vitro using MEGAscript SP6 Kit (Ambion, AM1330M) following the manufacturer's instructions.

### mRNA injection into one-cell embryos {#sec4.4.2}

Eggs were in vitro fertilized, dejellied using 2% Cystein solution in 0.1xMMR, pH 7.8, washed 3 times with 0.1x MMR and transferred into 0.5x MMR for injections. For Kdm5b wild-type and catalytic inactive mutant, 13.6 ng of mRNA was used per injection. For H3.3^WT^ and for H3.3^K4M^ 0.2ng and 1.25ng mRNA, respectively, was used per injection to obtain equal expression levels of the proteins in embryos. Embryos were cultured at 23°C and collected at neurula stage 18 (Kdm5b experiments) or stage 21 (H3.3 experiments) ([@bib29]) to prepare endoderm donor cells for nuclear transfer.

### Donor cell preparation {#sec4.4.3}

Endoderm cells were isolated from endoderm tissues of the respective neurula stage embryos (stage 18 for Kdm5b experiments; stage 21 for experiments shown in [Figures 1](#fig1){ref-type="fig"} and [2](#fig2){ref-type="fig"} or the H3.3 experiments, please also see above) and frozen on dry ice for further analysis or dissociated in calcium- and magnesium-free modified Barth saline (1xMBS; 88mM NaCl, 1mM KCl, 10mM HEPES, 2.5mM NaHCO3, pH to 7.4.) with 1 mM EDTA and 0.1% BSA in a petri dish covered with 1% agarose in H2O and used immediately for nuclear transplantation.

### Nuclear transfer and embryo culture {#sec4.4.4}

The procedure was carried out as described previously ([@bib15]). In brief, dissociated endoderm cells were mildly disrupted by pipetting them up and down gently in a glass micropipette. Nuclear transplantation was performed by injection of a whole permeabilized cell into an egg enucleated for 30 s with a UV mineralite lamp and dejellied by a 5 s Hanovia lamp treatment. Nuclear transfer was performed within the next minute. The nuclear transplant embryos were placed into 1x MBS 0.1% BSA. At the 4-cell stage, the medium was exchanged to 0.1xMBS. As control, embryos were in vitro fertilized and the embryos were cultured at 16°C in 0.1x MBS until they reached stage 7 or stage 11. For all our analyses, completely cleaved NT embryos were selected at stage 7, stage 10 or 11 that were morphologically indistinguishable from IVF embryos at the same stage. For experiments analyzing gene expression at stage 11, NT and IVF embryos with the same blastopore size and cell size were selected to ensure that they are all at the same developmental stage, and the animal cap cells (ectoderm) were isolated and frozen on dry ice for further analysis. To score the developmental outcome, embryos were cultured in 0.1xMBS at 16°C until neurula stage and then at room temperature until they reached the desired developmental stages, which were determined according to the developmental table of Nieuwkoop and Faber ([@bib29]) and counted.

### RNA extraction {#sec4.4.5}

Embryonic tissues were selected and isolated as described above, dissected as indicated and frozen at −80°C. RNA extractions were performed using QIAGEN RNeasy Mini kit (QIAGEN, 74106) according to the manufacturer's protocol including the DNase step. RNA was eluted in 40ul of DEPC H2O.

### cDNA sequencing library {#sec4.4.6}

RNA quality and quantity was analyzed on a RNA screen tape (Agilent) using RNA sample buffer (Agilent) on a Agilent 2200 tape station. Per sample, 500 ng RNA was used to generate a cDNA sequencing libraries using a Illumina TrueSeq kit (RS-122-2001), according to the manufacturer's protocol using 12 PCR amplification cycles.

### cDNA synthesis and RTqPCR analysis {#sec4.4.7}

cDNA synthesis was performed from the isolated RNAs using oligo dT(15) primers. RTqPCRs were performed with 5 μL cDNA and gene specific primers at 50 nM (Primer sequences are listed in [Table S4](#mmc1){ref-type="supplementary-material"}) using a SybrGreen detection system (Sigma, S9194) and ABI 7300 machine (Applied Biosystems) using standard ABI cycling conditions (two-step PCR cycle: 94°C for 15 s and 60°C for 60 s). Reactions were performed in a total volume of 25 μl.

### Western Blotting {#sec4.4.8}

Expression of mRNAs in embryos as well as the reduction of H3K4me3 levels was confirmed by western blot analyses. Briefly, embryonic tissues were homogenized in 50 μl buffer E1 (50mM HEPES-KOH pH 7.5, 140mM NaCl, 1mM EDTA pH 8.0, 10% Glycerol, 0.5% Igepal CA-630, 0.25% Triton X-100, 1mM DTT, complete protease inhibitors (Roche)) and then the chromatin was collected by centrifugation at 1600 g for 5 min. The supernatant was kept, the chromatin pellet was washed 3 times with 0.5ml Buffer E1 and then solubilized in 50 μL Emilie's Buffer (500mM Tris pH 6.8, 500mM NaCl, 1% NP40, 0.1% SDS, 1% β-Mercaptoethanol). Laemmli sample buffer was added to the lysate and chromatin fractions, samples were separated on a 15% polyacrylamide gel and transferred to Hybond-P membranes (Amersham Bioscience). Antibodies against H3K4me3 (Abcam ab8580), HA (Sigma, H9658) or histone H4 (Abcam ab31830) were used for western blotting according to standard protocols and suppliers recommendations.

### Chromatin Immunoprecipitation (ChiP) {#sec4.4.9}

Chromatin Immunoprecipitation (ChIP) were performed as described previously ([@bib13]) with the following modifications. Neurula (stage 18) embryos were generated by in vitro fertilization. For each ChIP experiment, 50 embryos were dissected in 1xMBS to obtain the endoderm tissue. Samples were fixed in 2 mL of 1% Formaldehyde in 0.1x MMR for 25 min at room temperature, followed by 4 washes with 1 mL 0.1xMMR and equilibration in 500 μL HEG solution (50mM HEPES-KOH pH 7.5, 1 mM EDTA, 20% Glycerol) at 4°C, then excess buffer was removed and samples were frozen at −80°C. To extract chromatin, the samples were homogenized in 2 mL buffer E1 (50mM HEPES-KOH pH 7.5, 140mM NaCl, 1mM EDTA pH 8.0, 10% Glycerol, 0.5% Igepal CA-630, 0.25% Triton X-100, 1mM DTT, complete protease inhibitors (Roche)). Chromatin was collected by centrifugation for 2 min at 3500 rmp, 4°C and then washed two times with 2 mL E1, three times with 2ml buffer E2 (10mM Tris pH 8.0, 200mM NaCl, 1mM EDTA, 0.5mM EGTA, complete protease inhibitors (Roche)) and three times with 500 μL Buffer E3 (10mM Tris pH 8.0, 200mM NaCl, 1mM EDTA, 0.5mM EGTA, 0.1% Na-deoxycholate, 0.5% N-lauroylsarcosine, complete protease inhibitors (Roche)). Chromatin was fragmented by sonication for 20 cycles (30 s on and 30 s off) using a Bioruptor (Diagenode) at 4°C. The samples were centrifuged at 15min, 4°C at full speed, the supernatant was collected and Triton X-100 was added to 1%. 25 μL of the solution were put aside to serve as Input for later analysis. Before ChIP, primary anti H3K4me3 (Abcam ab8580, 0.5 μg per 50 embryos) antibodies were bound to PBS washed magnetic beads conjugated with secondary antibody (Invitrogen 11204D, 25 μL per 50 embryos) in 500 μL 1xPBS 0.1% BSA overnight at 4°C on a rotating wheel. Beads were washed 3 times with 1xPBS 0.1% BSA, added to the fragmented chromatin solution and incubated overnight at 4°C on a rotating wheel. Beads were then washed 6 times with RIPA buffer (50mM HEPES-KOH pH 7.5, 500mM LiCl, 1mM EDTA, 1% Igepal CA-630, 0.7% Na-deoxycholate, complete protease inhibitors (Roche)) and twice with TEN buffer (10mM Tris pH 8.0, 1mM EDTA, 150mM NaCl, complete protease inhibitors (Roche)) for each 10 min. For crosslink reversal, the beads were resuspended in 150 μL Stop buffer (40mM Tris pH 8.0, 10mM EDTA, 1% SDS) and 125 μL Stop buffer was added to the input fraction. The samples were supplemented with Proteinase K (0.3 μg/μl), NaCl (250 mM) and incubated at 65°C overnight. RNase A (DNase free) was added to a final concentration of 200 μg/μl and DNA was Phenol/Chloroform extracted. 150 μg/μl Glycogen was added and DNA was recovered by Ethanol precipitation. The pellet was resuspended in 30 μL H2O.

### ChIP-seq library preparation {#sec4.4.10}

Half of a ChIP reaction (15 μl, see above) were subjected for ChIP-seq library preparation with the TruSeq DNA kit (Illumina, FC-121-2001). Two independent biological replicates were generated for each H3K4me3 ChIP experiments.

### ChIP-RTqPCR {#sec4.4.11}

The ChIP reaction (see above) was diluted 1:40 and 5 μL were used for subsequent RTqPCR analysis using primer pairs described in [Table S4](#mmc1){ref-type="supplementary-material"} at 50nM together with a SybrGreen detection system (Sigma, S9194) and ABI 7300 machine (Applied Biosystems) using standard ABI cycling conditions (two-step PCR cycle: 94°C for 15 s and 60°C for 60 s). Reactions are performed in a total volume of 25 μl.

### Experimental design {#sec4.4.12}

In all experiments analyzing gene expression, one sample was taken per embryo (i.e., one sample corresponds to one individual embryo). For the analysis of ON-memory gene-expression, 3 independent experiments (here defined as 3 biological replicates) were performed. In experiment\#1, 4 IVF-, 3 NT-ectoderm samples and 1 endoderm donor sample, in experiment\#2, 4 IVF-, 4 NT-ectoderm samples and 1 endoderm donor sample, in experiment\#3, 3 IVF-, 5 NT-ectoderm samples and 1 endoderm donor sample were generated (see [Table S1](#mmc1){ref-type="supplementary-material"}). To address the effect of Kdm5b, 2 independent experiments (here defined as two biological replicates) were performed. In experiment\#4, 4 NT(Kdm5b^wt^)- and 4 NT(Kdm5b^ci^) - ectoderm samples and 2 NT(Kdm5b^wt^)- and 2 NT(Kdm5b^ci^)- endoderm donor cell samples and in experiment\#5, 3 NT(Kdm5b^wt^)- and 4 NT(Kdm5b^ci^) - ectoderm samples and 2 NT(Kdm5b^wt^)- and 2 NT(Kdm5b^ci^)- endoderm donor cell samples were taken (see [Table S1](#mmc1){ref-type="supplementary-material"}). For the H3.3^K4M^ analysis, one experiment\#6 (one biological replicate) was performed with 4 IVF ectoderm samples, 4 NT(H3.3^wt^)- and 4 NT(H3.3^K4M^)- ectoderm samples and 2 NT(H3.3^wt^)- and 2 NT(H3.3^K4M^) - endoderm donor cell samples.

Randomization and Blinding: When the donor cells were treated, the order of nuclear transfer of control- and treated donor nuclei was alternated; The experimenter was unaware of the treatment of the donor cell while performing the nuclear transfer. When embryos were selected for analysis, healthy looking embryos (i.e., morphologically indistinguishable from IVF-embryos) with the same blastopore size were selected. A sample size was chosen that allowed the significant identification of differentially expressed genes (see quantification and statistical data analysis section below), and that also considered the loss of a third of the samples due to inefficient RNA extraction or a failure in library generation. Samples were excluded that showed poor RNA quality (RIN below 7), quantity (below 500ng) or that did not result in a product after performing the library preparation protocol. Furthermore, after sequencing, the raw reads were clustered using WardD, and out of 6 experiments, 3 experiments contained outliers: exp\#1: two NT-samples; exp\#3: one IVF-sample and exp\#5: one NT(Kdm5b^wt^)- sample. These 4 samples were excluded from further DE gene expression analysis.

For ChIP experiments, 2 independent experiments (here referred to as 2 biological replicates) were performed. Per ChIP experiment, the endoderm tissues of 50 Kdm5b^wt^-, 50 Kdm5b^ci^- expressing embryos, as well as 50 uninjected embryos were pooled.

For the quantification of the developmental outcome, 6 independent experiments (n) were performed, and the total number of gastrulae (N) was determined for each condition: 69 NT(Kdm5b^ci^)- and 56 NT(Kdm5b^ci^)- and 152 IVF- gastrula embryos. Gastrula embryos were selected, that were morphologically indistinguishable from IVF embryos at the same stage. Here, the biological replicates refer to the number of gastrula embryos quantified. Their development was followed, and surviving embryos were counted for each condition at the indicated stages. Randomization and Blinding: Per experiment, each condition was performed and the order was alternated; The experimenter was unaware of the treatment of the donor cell while performing the nuclear transfer and the quantification of the survival.

Quantification and Statistical Analysis {#sec4.5}
---------------------------------------

### *Xenopus* transcriptome and sequencing data {#sec4.5.1}

We used the *Xenopus laevis* annotation that was generated for ([@bib37]). RNA-seq and ChIP-seq libraries were sequenced on an Illumina HiSeq 2000 instrument in single read mode at 36 base length. Fastq files were filtered for low quality reads (\< Q20) using sickle and low quality bases were trimmed from the ends of the reads (\< Q20). Adapters were removed using cutadapt 1.0 ([@bib24]). RNA-seq data were mapped against the *Xenopus laevis* genome using TopHat 2.0.6 ([@bib39]) - *Xenopus laevis* genome (JGI version 6.1) was used for all analyses in this paper, and can be downloaded here: ftp://ftp.xenbase.org/pub/Genomics/JGI/Xenla6.1/.). ChIP-seq data mapped against *X. laevis* (version 6.1) with BWA (version 0.6.2) ([@bib21]). Duplicate reads in ChIP-seq were then filtered out with samtools 0.1.8 ([@bib22]). After this step, our input dataset contained more than 18 M uniquely mapped reads, and our IP samples more than 10 M uniquely mapped reads.

### *Xenopus* differential gene expression {#sec4.5.2}

For the expression profiling, read counts were generated for each of the transcripts. RPKMs (reads per kilobase per million) were calculated by normalizing read counts for each transcript by the transcript length and the total number of reads in the corresponding sample. Counts per million (CPM) and differentially expressed (DE) transcripts were called using edgeR ([@bib33]). For the analysis of the extent of transcriptional memory in [Figures 1](#fig1){ref-type="fig"} and [2](#fig2){ref-type="fig"}, transcripts remained in the analysis if they had CPM \> 1 in either all of the Donor or 70% of IVF or 70% of NT embryo samples. The log2 fold change (logFC) and the false discovery rate (FDR) was calculated comparing 11 IVF ectoderm samples, 12 NT ectoderm samples and 3 endoderm donor cell samples from 3 independent experiments (see [Table S1](#mmc1){ref-type="supplementary-material"}). To address the effect of Kdm5b, the DE analysis was performed on 8 IVF ectoderm samples, 7 NT(Kdm5b^wt^)- and 8 NT(Kdm5b^ci^) - ectoderm samples and 4 NT(Kdm5b^wt^)- and 4 NT(Kdm5b^ci^)- endoderm donor cell samples from 2 independent experiments (see [Table S1](#mmc1){ref-type="supplementary-material"}). The H3.3^K4M^ DE analysis was performed on 4 IVF ectoderm samples, 4 NT(H3.3^wt^)- and 4 NT(H3.3^K4M^)- ectoderm samples and 2 NT(H3.3^wt^)- and 2 NT(H3.3^K4M^) - endoderm donor cell samples from one experiment.

### Human differential gene expression {#sec4.5.3}

Publicly available datasets of the gene expression analysis were obtained from the Gene Expession Omnibus (GEO) DataSets, accession number [GSE73362](ncbi-geo:GSE73362){#intref0130} (human) ([@bib6]). The logFCs in gene expression levels were calculated in R.

### DE data filter-strategy {#sec4.5.4}

*X.Laevis*, log2 fold changes (logFC) and false discovery rate (FDR) were calculated by using the R package EdgeR. These lists of transcripts were then additionally filtered the following way (note that in the *Xenopus* analysis "3FC" corresponds log2FC \< 1.5 or log2FC \> 1.5, which is more precisely a 2.8285 fold change, and approximately a 3 fold change):

[DE transcripts Donor/IVF:]{.ul} FDR^Donor/IVF^ \< 0.05; [DE between Donor/IVF and NT/IVF]{.ul}: FDR^Donor/IVF^ \< 0.05&FDR^NT/IVF^ \< 0.05. [ON-memory]{.ul}: FDR^Donor/IVF^ \< 0.05, logFC^Donor/IVF^ \> 0, FDR^NT/IVF^ \< 0.05, logFC^NT/IVF^ \> 0, RPKM^Donor^ \> 1; [ON-memory(3FC)]{.ul}: FDR^Donor/IVF^ \< 0.05, logFC^Donor/IVF^ \> 0, FDR^NT/IVF^ \< 0.05, logFC^NT/IVF^ \> 1.5, RPKM^Donor^ \> 1; [OFF-memory:]{.ul} FDR^Donor/IVF^ \< 0.05, logFC^Donor/IVF^ \< 0, FDR^NT/IVF^ \< 0.05, logFC^NT/IVF^ \< 0; [OFF-memory(3FC):]{.ul} FDR^Donor/IVF^ \< 0.05, logFC^Donor/IVF^ \< 0, FDR^Donor/NT^ \< 0.05, logFC^Donor/NT^ \< 0, FDR^NT/IVF^ \< 0.05, logFC^NT/IVF^ \< −1.5; [Reprogrammed-down:]{.ul} FDR^Donor/IVF^ \< 0.05, logFC^Donor/IVF^ \> 0, FDR^Donor/NT^ \< 0.05, logFC^Donor/NT^ \> 0, RPKM^Donor^ \> 1; transcripts with FDR^NT/IVF^ \< 0.05 were excluded. Note that transcripts that were transcribed in the Donor (RPKM \> 1 in all Donor samples) but not in IVF and NT (RPKM \< 1 in some or all samples) were kept in the analysis and considered as ON-reprogrammed as they were successfully downregulated during reprogramming. [Reprogrammed-up:]{.ul} FDR^Donor/IVF^ \< 0.05, logFC^Donor/IVF^ \< 0, FDR^Donor/NT^ \< 0.05, logFC^Donor/NT^ \< 0, FDR^NT/IVF^ \> 0.05. [Reprogrammed:]{.ul} FDR^Donor/IVF^ \< 0.05, FDR^Donor/NT^ \< 0.05, transcripts with FDR^NT/IVF^ \< 0.05 were excluded.

Gene ontology terms over-represented among the differentially expressed genes were found using topGO ([@bib1]).

In the Kdm5b experiments, each of the two experiments was filtered separately and then the generated lists were intersected ([Figures 3](#fig3){ref-type="fig"}, [S3](#mmc1){ref-type="supplementary-material"}, and [S4](#mmc1){ref-type="supplementary-material"}; [Tables S2](#mmc1){ref-type="supplementary-material"} and [S3](#mmc1){ref-type="supplementary-material"}). DE transcripts between Kdm5b^wt^ versus Kdm5b^ci^ expressing donor and H3.3^wt^ versus H3.3^K4M^ expressing donor cells were identified by filtering for FDR \< 0.05 and then excluded from further analysis. The different gene sets upon Kdm5b^ci^ treatment were filtered the following way:

[DE transcripts Donor]{.ul}^[ci]{.ul}^[/IVF:]{.ul} FDR^Donorci/IVF^ \< 0.05; [DE between Donor]{.ul}^[ci]{.ul}^[/IVF and NT]{.ul}^[ci]{.ul}^[/IVF]{.ul}: FDR^Donorci/IVF^ \< 0.05&FDR^NTci/IVF^ \< 0.05. [ON-memory]{.ul}: FDR^Donorci/IVF^ \< 0.05, logFC^Donorci/IVF^ \> 0, FDR^NTci/IVF^ \< 0.05, logFC^NTci/IVF^ \> 0, RPKM^Donorci^ \> 1; [ON-memory(3FC)]{.ul}: FDR^Donorci/IVF^ \< 0.05, logFC^Donorci/IVF^ \> 0, FDR^NTci/IVF^ \< 0.05, logFC^NTci/IVF^ \> 1.5, RPKM^Donocir^ \> 1; [OFF-memory:]{.ul} FDR^Donorci/IVF^ \< 0.05, logFC^Donorci/IVF^ \< 0, FDR^NTci/IVF^ \< 0.05, logFC^NTci/IVF^ \< 0; [OFF-memory(3FC):]{.ul} FDR^Donorci/IVF^ \< 0.05, logFC^Donorci/IVF^ \< 0, FDR^Donorci/NT^ \< 0.05, logFC^Donorci/NT^ \< 0, FDR^NTci/IVF^ \< 0.05, logFC^NTci/IVF^ \< −1.5; [Reprogrammed-down:]{.ul} FDR^Donorci/IVF^ \< 0.05, logFC^Donorci/IVF^ \> 0, RPKM^Donorci^ \> 1; transcripts with FDR^NT/IVF^ \< 0.05 were excluded. Note that transcripts that were transcribed in the Donor (RPKM \> 1 in all Donor samples) but not in IVF and NT (RPKM \< 1 is some or all samples) were kept in the analysis and considered as ON-reprogrammed as they were successfully downregulated during reprogramming. [Reprogrammed-up:]{.ul} FDR^Donorci/IVF^ \< 0.05, logFC^Donorci/IVF^ \< 0, FDR^NTci/IVF^ \> 0.05. [Reprogrammed:]{.ul} FDR^Donorci/IVF^ \< 0.05, transcripts with FDR^NTci/IVF^ \< 0.05 were excluded

The different gene sets upon Kdm5b^wt^, H3.3^wt^ and H3.3^K4M^ treatment were filtered following the same strategy as above.

In human and mouse, the values for log2 FC (logFC) were filtered using R. These lists of transcripts were then additionally filtered the following way:

[DE transcripts between Donor/IVF:]{.ul} FC^Donor/IVF^ \> 5; [DE between Donor/IVF and NT/IVF]{.ul}: FC^Donor/IVF^ \> 5 and FC^NT/IVF^ \> 5. [ON-memory(2-5FC)]{.ul}: logFC^Donor/IVF^ \> 2.3, 1 \< logFC^NT/IVF^ \< 2.3, RPKM^Donor^ \> 1; [ON-memory(5FC)]{.ul}:, logFC^Donor/IVF^ \> 2.3, logFC^NT/IVF^ \> 2.3, FPKM^Donor^ \> 1; [OFF-memory(2-5FC):]{.ul} logFC^Donor/IVF^ \< −2.3, −2.3 \< logFC^NT/IVF^ \< −1; [OFF-memory(5FC):]{.ul} logFC^Donor/IVF^ \< −2.3, logFC^NT/IVF^ \< −2.3; [Reprogrammed-down:]{.ul} logFC^Donor/IVF^ \> 2.3, RPKM^Donor^ \> 1; transcripts with logFC^NT/IVF^ \> 1 were excluded. Note that genes that were transcribed in the Donor (FPKM \> 1 in all Donor samples) but not in IVF and NT (FPKM \< 1 in some or all samples) were kept in the analysis and considered as ON-reprogrammed as they were successfully downregulated during reprogramming. [Reprogrammed-up:]{.ul} logFC^Donor/IVF^ \< −2.3, logFC^NT/IVF^ \> −1. [Reprogrammed]{.ul}: union of ON- and OFF- reprogrammed transcripts.

### Heatmaps and plots for gene expression {#sec4.5.5}

Heatmaps. The log2 fold change was calculated over the mean IVF expression level or over the mean pooled donor, IVF and NT expression level, as indicated in figure legends. These values were plotted on a heatmap and clustered by rows only or by both rows and columns, as shown in figure legends, using heatmap.2 (from R package *gplots*) using default settings (which is complete as agglomeration method and Euclidean distance as similarity measure). MA plot. The log2 FC in expression of transcripts between NT- to IVF-embryos was plotted against the average donor cell gene expression (log2(RPKM+1)). Box-plots show distribution of mean gene expression levels of the different sets of transcripts. The middle line in the box indicates the median, the box edges indicate the 25th/75th percentiles, the whiskers indicate the min and max.

Differences in gene expression levels between pairwise sets of genes were tested using Mann-Whitney test (equivalent to Wilcoxon rank sum test. R, wilcox.test(alternative = c("two.sided"), paired = F)).

### qPCR analysis {#sec4.5.6}

The indicated genes were quantified using a standard curve of embryonic cDNA (gene expression) or *Xenopus* genomic DNA (ChIP). For normalization, the values of the genes of interest were divided by the values for H4 (gene expression) or the values of the IP were represented as percent of the Input values (ChIP). The data were then visualized using R as a scatterplot, with the mean and the standard error of the mean (gene expression); each dot on the scatterplot corresponds to one embryo sample generated in two independent experiments) or the mean as a column bar graph with the standard error of the mean (ChIP; each bar corresponds to two values generated in two independent experiments). When indicated, significance was calculated using Mann-Whitney test (equivalent to Wilcoxon rank sum test. R, wilcox.test(alternative = c("two.sided"), paired = F)). ^∗^p value \< 0.05, ^∗∗^p value \< 0.01, ^∗∗∗^p value \< 0.001.

### Principal component analysis and hierarchical transcriptome clustering {#sec4.5.7}

After computing CPM (count per million), genes were retained in the analysis if they had CPM \> 1 in either all of the Donor or in ≥ 70% of IVF or ≥ 70% of NT embryo samples. The data were subsequently scaled two times using z-score transformation: one scaling has been performed for each batch of experiments (i.e., experiments produced at the same time). Then all batched experiments have been scaled together again to reduce the variability due to the technical batch factor. Data obtained after this step have been used for the unsupervised hierarchical clustering analysis, which was performed by using the Euclidean distance and ward.D linkage as implemented in R. The PCA analysis was performed using the R function prcomp() using the parameter cor = T.x.

### ChIP-seq data analysis {#sec4.5.8}

Aligned data from H3K4me3 ChIP-seq were used to compute the coverage around TSS (transcriptional start site) for each of the two biological replicates separately. The histone methylation levels was computed as:$$Histone\ Methylation\ level = \ \frac{Coverage_{IP}}{N_{IP}}10^{6} - \frac{Coverage_{input}}{N_{input}}10^{6}$$where IP is the immunoprecipitation sample, *input* is the input-control; N~IP~ is the total number of aligned reads in the IP experiment and N~input~ is the total number of aligned reads in the input sample.

Specifically, a region of 4kb centered on the TSSs was binned in 50bp-wide windows and the histone methylation level was computed for each bin. The average of the normalized histone methylation levels was computed for each set of genes (ON-memory, ON-reprogrammed, genome-wide (GW)) and then visualized. Differences in histone methylation levels at TSSs between the set of genes were tested with the Kolmogorov-Smirnov test (R, ks.test).

Additionally, the global (integral) histone methylation level in the 4kb window was computed and the distribution across each set of genes was visualized in box-plots and compared using ks.test. For signal tracks, count reads were computed with bedtools (version 2.25.0) genomecov ([@bib32]).

Processed and normalized bigwig files relative to H3K4me3 in adult normal human dermal fibroblast (NHDF) cells were downloaded from GEO (GEO accession number [GSM733650](ncbi-geo:GSM733650){#intref0135}). The same strategy was used to compare the average histone methylation levels of different groups of genes in a region of 2kb around TSS as indicated.

### Methylated histone regions {#sec4.5.9}

Histone methylated regions (peaks) were called using MACS2 (version 2.0.9) with the following options (--broad--gsize = 2.6e9 -q 0.01) for each immunoprecipitation experiment individually. Resulting peaks overlapping TSSs were used for the subsequent analysis. Peaks sizes distributions were visualized by plotting histograms. The inserts with examples of H3K4me3 regions spanning the TSS of example genes were generated using Integrative Genomics Viewer, IGV ([@bib34], [@bib38]). KS test was used to evaluate differences between peaks sizes across the different set of previously defined genes. ECDFs (empirical cumulative distribution functions) were computed for all experiments and visualized.

We downloaded peaks list of the human study in NHDF cells (GEO accession number [GSM733650](ncbi-geo:GSM733650){#intref0140}). Peak sizes distributions of different set of genes were compared similarly.

### Developmental outcome {#sec4.5.10}

Statistical significance was calculated using a one tailed t test using R. The data are represented as the mean with the SEM (standard error of the mean).

Data Availability {#sec4.6}
-----------------

The RNA-seq and ChIP-seq data generated in this study are: 73 samples, single-ended RNA-seq libraries from neurula stage 18 or 21 endoderm and gastrula stage 11 ectoderm samples; 2 single-ended ChIP-seq libraries from endoderm cells of neurula (stage 21) embryos with antibody for H3K4me3, and 2 replicates for each histone modification pull-down. The accession number for the RNA-seq and ChIP-seq data reported in this paper is GEO: [GSE92366](ncbi-geo:GSE92366){#intref0145}.
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